This observation is significant, as it has previously been claimed [12,21] that the use of this plasma biomarker as an independent CV outcome marker in CKD may be precluded by the substantial association between NT-proBNP and GFR, which is caused by decreased renal clearance of NT-proBNP in advanced CKD. Here, NPPB is linked to chronic kidney disease.